<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Articles</title>
<copyright>Copyright (c) 2013 Dublin Institute of Technology All rights reserved.</copyright>
<link>http://arrow.dit.ie/otpomart</link>
<description>Recent documents in Articles</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 May 2013 01:38:54 PDT</lastBuildDate>
<ttl>3600</ttl>


	
		
	







<item>
<title>Evidence of Lower Macular Pigment Optical Density in Chronic Open Angle Glaucoma</title>
<link>http://arrow.dit.ie/otpomart/32</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/32</guid>
<pubDate>Mon, 20 May 2013 02:30:34 PDT</pubDate>
<description>
	<![CDATA[
	<p><p id="x-x-p-1"><strong>Background/aims</strong> Macular pigment (MP) plays an important role in visual function and in the protection of the retina from oxidative damage. It is not known whether glaucoma, a progressive neurodegenerative disease of the optic nerve, is associated with alterations in MP. This study was designed to investigate the relationship, if any, between the optical density of MP optical density (MPOD) and glaucoma.    <p id="x-x-p-2"><strong>Methods</strong> 40 subjects (23 males, 17 females) with open angle glaucoma (mean age 69 ±11), and 54 normal controls (23 males, 31 females) without ocular disease (mean age 66 ±11), visual acuity (VA) >6/18, were recruited, and underwent a comprehensive eye examination including biomicroscopy, fundoscopy, Goldmann tonometry and visual field assessment, using the 24-2 SITA-fast algorithm on the Humphrey visual field analyser (II-i Series). MPOD, at 0.5° of retinal eccentricity was determined, for all subjects, using heterochromatic flicker photometry.    <p id="x-x-p-3"><strong>Results</strong> Median (IQR) MPOD for subjects with glaucoma was 0.23 (0.42) compared to 0.36 (0.44) for controls. The difference in MPOD between the glaucoma cases and controls was statistically significant (z=−2.158, p=0.031). There was no significant correlation (p>0.05) between MPOD and disease severity.    <p id="x-x-p-4"><strong>Conclusions</strong> These findings suggest that MPOD is lower in patients with glaucoma. Further investigation is needed to determine the significance of MP in glaucoma, its relationship to glare symptoms in glaucoma and to assess what role therapeutic strategies aimed at increasing MP levels could have in the management of glaucoma.</p>

	]]>
</description>

<author>Estera Igras et al.</author>


</item>






<item>
<title>The Development of a Public Optometry System in Mozambique: a Cost Benefit Analysis</title>
<link>http://arrow.dit.ie/otpomart/31</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/31</guid>
<pubDate>Thu, 25 Apr 2013 01:00:41 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Stephen J. Thompson et al.</author>


</item>






<item>
<title>Education is Positively Associated with Macular Pigment: the Irish Longitudinal Study on Ageing (TILDA)</title>
<link>http://arrow.dit.ie/otpomart/30</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/30</guid>
<pubDate>Tue, 23 Apr 2013 03:02:14 PDT</pubDate>
<description>
	<![CDATA[
	<p>The three carotenoids lutein, zeaxanthin, and meso-zeaxanthin, are found at the macula and referred to as macular pigment (MP). This study was undertaken to investigate determinants of MP in a large randomly selected sample from the Republic of Ireland (as part of The Irish Longitudinal Study on Ageing [TILDA]).  <h4>METHODS:</h4></p>
<p>MP optical density (MPOD) was measured using customized heterochromatic flicker photometry in 4373 participants. Sociodemographic and self reported health data was obtained using computer assisted personal interview (CAPI).  <h4>RESULTS</h4></p>
<p>Mean (SD) MPOD for the study group was 0.203 (0.156) with a range of 0 to 1.01. MPOD was higher for participants with secondary education (mean [SD] = 0.205 [0.148]) than for those with only primary education or no education (mean [SD] = 0.183 [0.113]; P < 0.001). MPOD was also higher for those with tertiary education (mean [SD] = 0.232 [0.231]) compared with primary/no education or secondary education (P < 0.001 for both comparisons).  <h4>CONCLUSIONS:</h4></p>
<p>We report that MP is lower amongst those participants of a population-representative study who did not have secondary or third level education when compared with participants who had such education. Given the emerging evidence that MP is important for visual performance and comfort, and given the putative protection that this pigment confers against AMD (especially important in the context of increased risk of AMD in this social group), public health measures aimed at improving diet for this at-risk population need to be considered.    <dl><dd></dd> <dd>[PubMed - indexed for MEDLINE]</dd></dl></p>

	]]>
</description>

<author>John Nolan et al.</author>


</item>






<item>
<title>Macular Pigment: Its Associations with Color Discrimination and Matching</title>
<link>http://arrow.dit.ie/otpomart/29</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/29</guid>
<pubDate>Thu, 18 Apr 2013 07:10:38 PDT</pubDate>
<description>
	<![CDATA[
	<p><strong>Purpose</strong></p>
<p>Macular pigment (MP) acts as a pre-receptoral filter which selectively absorbs short wavelengths. It has the potential to alter color vision but the literature is conflicting on whether it does and, if so, to what extent, possibly reflecting differences between color mechanisms and color tests. This study was designed to identify and investigate relationships, if any, between macular pigment optical density (MPOD) and color sensitivity using a battery of techniques to quantify the color vision of color-normal observers.</p>
<p><strong>Methods</strong></p>
<p>Color vision was assessed with the Farnsworth-Munsell 100-Hue test (FM100), Moreland match on the HMC anomaloscope, and a customized SWAP (short wavelength automated perimetry) technique at the foveola and at 1, 2, 3, 4 and 5 degrees eccentricity. MPOD spatial profile was measured using customized heterochromatic flicker photometry.</p>
<p><strong>Results</strong></p>
<p>Total error scores (TES) and % partial error scores (%PES) on the FM100 were uncorrelated to MPOD. Moreland matches showed a significant long wavelength shift with MPOD at between 1 and 3 degrees (at 1.75 degrees, r= 0.489, p< .001). Sensitivities on customized SWAP (cSWAP) using foveal targets were significantly inversely correlated with MPOD at both 1.75 degrees (r = -0.461, p < .001) and 3 degrees (r = - .393, p < .001). Partial correlation analysis suggests that none of these findings can be attributed to age effects within the range 18 to 40 years.</p>
<p><strong>Conclusions</strong></p>
<p>Our findings suggest that dietary supplementation to increase MPOD is unlikely to adversely affect hue discrimination. The association of MPOD with cSWAP may be a temporally limited effect to which the visual system normally adapts. We suggest that cSWAP may provide a clinical tool for assessing short-wavelength foveal sensitivity.</p>

	]]>
</description>

<author>Peter Davison et al.</author>


</item>






<item>
<title>One Student One Family and the Mozambique Eyecare Project</title>
<link>http://arrow.dit.ie/otpomart/28</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/28</guid>
<pubDate>Mon, 11 Mar 2013 10:10:29 PDT</pubDate>
<description>
	<![CDATA[
	<p><strong>Background - </strong>The Mozambique Eyecare Programme is funded by Irish Aid and designed to address the need for optometric education in Lusophone Africa. It is a multi-partner collaboration between Universidade Lúrio, Mozambique, Dublin Institute of Technology, Ireland, University of Ulster, Northern Ireland, and The International Centre for Eyecare Education (ICEE) an international Non Government Organisation. A key output from the programme is the development of an optometry school based at Universidade Lúrio, the first of its kind in Mozambique. The aim is to address unmet eye care needs through human resource development.</p>
<p>All students enrolled at Universidade Lúrio, including the optometry students, are required to participate in the One Student One Family programme. This initiative aims to improve the public health of disadvantaged communities in Nampula province through information dissemination and increased interaction between health science students and the general public. It also provides the students with the opportunity to interact with the community and apply their theoretical knowledge in the local context. This experience will enhance their patient care and as it is a community informed project, it ensures the wider eyecare programme follows a pro-poor approach.</p>
<p><strong>Aim - </strong>This paper aims to analyse the lessons learnt from the programme so far.</p>
<p><strong>Methods - </strong>Surveys and key informant interviews with optometry students, individuals within communities, teaching faculty and partners involved with the Mozambique Eyecare Project will form the basis of the analysis.</p>
<p><strong>Results - </strong>The results are expected to indicate both the successes and failures of the One Student One Family programme. The results will contribute to the development of a framework to improve the programme in order to achieve the desired outcome of improved community eye health.</p>
<p><strong>Conclusion - </strong>The Mozambique Eyecare Project is developing human resources in Lusophone Africa through a partnership linking higher education institutions in Europe and Africa. The One Student One Family programme addresses a current deficit in eyecare knowledge within the local community by transferring knowledge from optometry students to the general public.</p>
<p>In conclusion, innovative models of education and interaction between students and the community is necessary to address the eye care needs of the country, the region and the continent.</p>

	]]>
</description>

<author>Stephen J. Thompson et al.</author>


</item>






<item>
<title>The challenges faced by Portuguese-speaking universities in Africa</title>
<link>http://arrow.dit.ie/otpomart/26</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/26</guid>
<pubDate>Mon, 11 Mar 2013 03:25:23 PDT</pubDate>
<description>
	<![CDATA[
	<p>A common challenge faced by members of the Association of Portuguese Language Universities (AULP) and by other higher education institutions around the world is providing access to up-to-date and relevant academic literature. In an age where more research is being published than ever before, institutions need to move with the times and recognise that we should change our approach to tertiary education. This report considers how a university based in a Portuguese speaking country can use e-learning to overcome some of the barriers presented by language in higher education.</p>

	]]>
</description>

<author>Stephen J. Thompson et al.</author>


</item>






<item>
<title>Visual Performance in Patients with Neovascular Age Related Macular Degeneration Undergoing Treatment With Intravitreal Ranibizumab</title>
<link>http://arrow.dit.ie/otpomart/25</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/25</guid>
<pubDate>Tue, 05 Mar 2013 02:10:27 PST</pubDate>
<description>
	<![CDATA[
	<p>Purpose. To assess visual function and its response to serial intravitreal ranibizumab (Lucentis, Genentech) in patients with neovascular age-related macular degeneration (nv-AMD).</p>
<p><em><em>Methods</em></em>. Forty-seven eyes of 47 patients with nv-AMD, and corrected distance visual acuity (CDVA) logMAR 0.7 or better, undergoing intravitreal injections of ranibizumab, were enrolled into this prospective study. Visual function was assessed using a range of psychophysical tests, while mean foveal thickness (MFT) was determined by optical coherence tomography (OCT).</p>
<p><em><em>Results</em></em>. Groupmean (±sd)MFT reduced significantly frombaseline (233±59)) to exit (205±40)) (p = 0.001). CDVA exhibited no change between baseline and exit visits (p = 0.48 and p = 0.31 resp.). Measures of visual function that did exhibit statistically significant improvements (p < 0.05 for all) included reading acuity, reading speed, mesopic and photopic contrast sensitivity (CS), mesopic and photopic glare disability (GD), and retinotopic ocular sensitivity (ROS) at all eccentricities.</p>
<p><em><em>Conclusion</em></em>. Eyes with nv-AMD undergoing intravitreal ranibizumab injections exhibit improvements in many parameters of visual function. Outcome measures other than CDVA, such as CS, GD, and ROS, should not only be considered in the design of studies investigating nv-AMD, but also in treatment and retreatment strategies for patients with the condition.</p>

	]]>
</description>

<author>James Loughman</author>


</item>






<item>
<title>Impact of Dietary Carotenoid Deprivation on Macular Pigment and Serum Concentrations of Lutein and Zeaxanthin</title>
<link>http://arrow.dit.ie/otpomart/24</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/24</guid>
<pubDate>Tue, 30 Oct 2012 08:30:37 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>James Loughman et al.</author>


</item>






<item>
<title>Clinical Applicability of the Macular Degeneration Detection Device (MDD-2): a Novel Photostress Recovery Measurement Device</title>
<link>http://arrow.dit.ie/otpomart/23</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/23</guid>
<pubDate>Tue, 30 Oct 2012 08:30:36 PDT</pubDate>
<description>
	<![CDATA[
	<p>Background: Diseases affecting the macula, such as age-related macular degeneration (AMD), diabetic retinopathy and central serous retinopathy can result in impaired photostress recovery time (PSRT) despite normal visual acuity and fundoscopic appearance. The MDD-2 Macular Degeneration Detection Device is a novel flash photostress recovery device. In this study, we examine the repeatability of the MDD-2 in a normal population and its suitability for incorporation into routine clinical practice. Methods: One hundred (60 female) subjects (mean age 35+-8 years; range 18 to 66 years) were recruited to partake in this study. The photostress recovery time was measured using the MDD-2 on three occasions in the dominant eye and one final occasion in the non-dominant eye to assess measurement repeatability. All subjects were in good ocular health. Visual acuity and iris colour were recorded for each participant. Results: Repeated measures analysis of variance revealed a statistically significant learning effect on intra-measurement repeatability (p < 0.01). Although paired t-test analysis revealed statistically significant differences between repeated measures both within and between eyes (p < 0.05 for all) the correlation between repeat measurements is statistically significant (p < 0.05 for all), and the coefficient of repeatability reaches clinically acceptable levels once the initial photostress recovery time, which demonstrated increased variability and latency compared to all subsequent measures, is excluded. Conclusion: The MDD-2 provides highly repeatable measurements of photostress recovery time among young naïve subjects, following verbal explanation of the task and only one ‘practise’ measurement. The measurement is also highly repeatable between eyes, providing a potential immediate clinical biomarker of ocular health.</p>

	]]>
</description>

<author>James Loughman et al.</author>


</item>






<item>
<title>Prognostic Indicators and Outcome Measures for Surgical Removal of Symptomatic Nonadvanced Cataract</title>
<link>http://arrow.dit.ie/otpomart/22</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/22</guid>
<pubDate>Tue, 05 Jun 2012 08:43:09 PDT</pubDate>
<description>
	<![CDATA[
	<p>Obectives:</p>
<p>To report changes in perceived visual functioning after surgery for symptomatic cataract with pre-operative corrected distance visual acuity [CDVA] of 0.4 logMar or better (Snellen equivalent, 20/50) and to investigate the relationship between any observed changes and preoperative physical characteristics and psycho-physical consquences of the lens opacity and any changes in psychophysical findings after the procedure.</p>

	]]>
</description>

<author>Sofia Charalampidou et al.</author>


</item>






<item>
<title>Supplementation with All Three Macular Carotenoids: Response, Stability, and Safety</title>
<link>http://arrow.dit.ie/otpomart/18</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/18</guid>
<pubDate>Mon, 21 May 2012 03:48:02 PDT</pubDate>
<description>
	<![CDATA[
	<p><p id="x-x-x-p-1"><strong>Purpose</strong> This study was designed to investigate serum and macular response, and safety, to supplementation with <em>meso</em>-zeaxanthin (MZ), lutein (L) and zeaxanthin (Z), the carotenoids that constitute macular pigment (MP).  <p id="x-x-x-p-2"><strong>Materials and Methods</strong> 44 healthy subjects were recruited into this randomized, placebo-controlled, clinical trial. Subjects consumed one tablet per day containing 10.6 mg MZ, 5.9 mg L and 1.2 mg Z (Intervention, I group) or placebo (P group). The spatial profile of MP optical density (MPOD) was measured using heterochromatic flicker photometry (HFP), and serum concentrations of L and Z were quantified using high performance liquid chromatography (HPLC). Subjects were assessed at baseline, three and six months. Clinical pathology analysis was performed at baseline and six months.  <p id="x-x-x-p-3"><strong>Results</strong> Serum concentrations of L and Z increased significantly in the I group (p = 0.001 and 0.003, respectively) and remained stable in the P group (p > 0.05). There was a significant increase in central MPOD in the I group (0.25°: p = 0.001; 0.5: p = 0.001), with no significant change in the P group (p > 0.05). Clinical pathology analysis confirmed that all variables remained within the normal reference range, with the exception of total cholesterol and low density lipoprotein (LDL), which exhibited baseline values outside the accepted normal reference range prior to supplementation.  <p id="x-x-x-p-4"><strong>Conclusion</strong> Subjects supplemented with MZ, L and Z exhibit significant increases in serum concentrations of these carotenoids, and a subsequent increase in central MPOD. Pathology analysis suggests no adverse clinical implications of consuming these carotenoids.</p>

	]]>
</description>

<author>Eithne E. Connolly et al.</author>


</item>






<item>
<title>A Review of the Evidence Germane to the Putative Protective Role of the Macular Carotenoids for Age-Related Macular Degeneration</title>
<link>http://arrow.dit.ie/otpomart/21</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/21</guid>
<pubDate>Mon, 21 May 2012 03:47:25 PDT</pubDate>
<description>
	<![CDATA[
	<p>There is a consensus that age-related macular degeneration (AMD) is the result of (photo)- oxidative-induced retinal injury and its inflammatory sequelae, the latter being influenced by genetic background. The dietary carotenoids, lutein (L), zeaxanthin (Z), and meso-zeaxanthin (meso-Z), accumulate at the macula, where they are collectively known as macular pigment (MP). The anatomic (central retinal), biochemical (anti-oxidant) and optical (short-wavelength- filtering) properties of this pigment have generated interest in the biologically plausible rationale that MP may confer protection against AMD. Level 1 evidence has shown that dietary supplementation with broad-spectrum anti-oxidants results in risk reduction for AMD progression. Studies have demonstrated that MP rises in response to supplementation with the macular carotenoids, although level 1 evidence that such supplementation results in risk reduction of AMD and/or its progression is still lacking. Although appropriately weighted attention should be accorded to higher levels of evidence, the totality of available data should be appraised in an attempt to inform professional practice. In this context, the literature demonstrates that supplementation with the macular carotenoids is probably the best means of fortifying the anti-oxidant defenses of the macula, thus putatively reducing the risk of AMD and/or its progression.</p>

	]]>
</description>

<author>Sarah Sabour-Pickett et al.</author>


</item>






<item>
<title>Online AMD Research Study for Optometrists: Current Practice in the Republic of Ireland and UK</title>
<link>http://arrow.dit.ie/otpomart/20</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/20</guid>
<pubDate>Mon, 21 May 2012 03:47:23 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>James Loughman et al.</author>


</item>






<item>
<title>An Evaluation of a Novel Instrument for Measuring Macular Pigment Optical Density: the MPS 9000</title>
<link>http://arrow.dit.ie/otpomart/19</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/19</guid>
<pubDate>Mon, 21 May 2012 03:47:22 PDT</pubDate>
<description>
	<![CDATA[
	<p><strong>Purpose: </strong> Of the antioxidants found in the human retina, only the macular carotenoid quantities can be estimated noninvasively (albeit in a collective fashion), thus facilitating study of their role in that tissue. The aim of this study was to evaluate concordance between macular pigment optical density (MPOD) values recorded on a commercially available instrument, the MPS 9000, with those of an already validated heterochromatic flicker photometry instrument. Also, we assessed and compared test–retest variability for each instrument.</p>
<p><strong>Methods: </strong> Macular pigment optical density at 0.5 retinal eccentricity was measured using two different heterochromatic flicker photometers, the MPS 9000 and the Macular Densitometer<sup>TM</sup>, in 39 healthy subjects. Test–retest variability was evaluated separately for each instrument by taking three readings over a 1-week period in 25 subjects.</p>
<p><strong>Results: </strong> There was a moderate positive correlation for MPOD at 0.5° of retinal eccentricity between the MPS 9000 and the Macular Densitometer described by the linear equation <em>y</em> = 0.763<em>x</em> + 0.172 (<em>r</em> = 0.68, p < 0.001, <em>r</em><sup>2</sup> = 0.46); however, a paired-samples <em>t</em>-test showed a significant difference in terms of mean values, with a bias of lower MPOD values being yielded by the MPS 9000 (<em>t</em> = −4.103, p < 0.001). Bland–Altman analysis indicated only moderate agreement between the two instruments, reflected in 95% limits of agreement of 0.1 ± 0.27. Inter-sessional repeatability, expressed as a coefficient of repeatability, ranged from 0.18 to 0.21 [mean (±SD): 0.19 (0.02)] for the MPS 9000 and from 0.11 to 0.12 [mean (±SD): 0.12 (0.01)] for the Macular Densitometer.</p>
<p><strong>Conclusion: </strong> The results demonstrate that the MPS 9000 consistently yields MPOD readings, which are lower than that found with the Macular Densitometer, and exhibits substantial test–retest variability.</p>

	]]>
</description>

<author>James Loughman et al.</author>


</item>






<item>
<title>Estimation of Effective Lens Position Using a Method Independent of Preoperative Keratometry Readings</title>
<link>http://arrow.dit.ie/otpomart/17</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/17</guid>
<pubDate>Fri, 08 Apr 2011 05:38:10 PDT</pubDate>
<description>
	<![CDATA[
	<p><h3>Purpose</h3></p>
<p>To evaluate the validity of a keratometry  (K)-independent method of estimating effective lens position (ELP)  before phacoemulsification cataract surgery.  <h3>Setting</h3></p>
<p>Institute of Eye Surgery, Whitfield Clinic, Waterford, Ireland.  <h3>Design</h3></p>
<p>Evaluation of diagnostic test or technology.  <h3>Methods</h3></p>
<p>The  anterior chamber diameter and corneal height in eyes scheduled for  cataract surgery were measured with a rotating Scheimpflug camera.  Corneal height and anterior chamber diameter were used to estimate the  ELP in a K-independent method (using the SRK/T [ELP<sub>rs</sub>] and Holladay 1 [ELP<sub>rh</sub>] formulas).  <h3>Results</h3></p>
<p>The mean ELP was calculated using the traditional (mean ELP<sub>s</sub> 5.59 mm ± 0.52 mm [SD]; mean ELP<sub>h</sub> 5.63 ± 0.42 mm) and K-independent (mean ELP<sub>rs</sub> 5.55 ± 0.42 mm; mean ELP<sub>rh</sub> ± SD 5.60 ± 0.36 mm) methods. Agreement between ELP<sub>s</sub> and ELP<sub>rs</sub> and between ELP<sub>h</sub> and ELP<sub>rh</sub> were represented by Bland-Altman plots, with mean differences (± 1.96 SD) of 0.06 ± 0.65 mm (range −0.59 to +0.71 mm; <em>P</em>=.08) in association with ELP<sub>rs</sub> and −0.04 ± 0.39 mm (range −0.43 to +0.35 mm; <em>P</em>=.08) in association with ELP<sub>rh</sub>. The mean absolute error for ELP<sub>s</sub> versus ELP<sub>rs</sub> estimation and for ELP<sub>h</sub> versus ELP<sub>rh</sub> estimation was 0.242 ± 0.222 mm (range 0.001 to 1.272 mm) and 0.152 ± 0.137 mm (range 0.001 to 0.814 mm), respectively.  <h3>Conclusion</h3></p>
<p>This  study confirms that the K-independent ELP estimation method is  comparable to traditional K-dependent methods and may be useful in  post-refractive surgery patients.</p>

	]]>
</description>

<author>I. Dooley et al.</author>


</item>






<item>
<title>The Impact of Macular Pigment Augmentation on Visual Performance in Normal Subjects: COMPASS</title>
<link>http://arrow.dit.ie/otpomart/16</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/16</guid>
<pubDate>Fri, 25 Mar 2011 07:03:17 PDT</pubDate>
<description>
	<![CDATA[
	<p>This study was conducted to investigate whether augmentation of macular pigment (MP) enhances visual performance (VP). 121 normal subjects were recruited. The active (A) group consumed 12 mg of lutein (L) and 1 mg of zeaxanthin (Z) daily. MP optical density (MPOD) was assessed by customized heterochromatic flicker photometry. VP was assessed as best corrected visual acuity (BCVA), mesopic and photopic contrast sensitivity (CS), glare disability, photostress, and subjective visual function. Subjects were assessed at baseline; 3; 6; 12 months (V1, V2, V3 and V4, respectively). Central MPOD increased significantly in the A group (<em>p</em> < 0.05) but not in the placebo group (<em>p</em> > 0.05). This statistically significant increase in MPOD in the A group was not, in general, associated with a corresponding improvement in VP (<em>p</em> > 0.05, for all variables), with the exception of a statistically significant time/treatment effect in “daily tasks comparative analysis” (<em>p</em> = 0.03). At V4, we report statistically significant differences in mesopic CS at 20.7 cpd, mesopic CS at 1.5 cpd under high glare conditions, and light/dark adaptation comparative analysis between the lower and the upper MP tertile groups (<em>p</em> < 0.05) Further study into the relationship between MP and VP is warranted, with particular attention directed towards individuals with low MP and suboptimal VP.  <h4>Research highlights</h4></p>
<p>► Identifying that macular pigment significantly increased in the active group. ► Less glare disability for subjects with high macular pigment. ► Improved mesopic contrast sensitivity for subjects with high macular pigment. ► Identifying the need for further research in subjects with low macular pigment.</p>

	]]>
</description>

<author>John Nolan et al.</author>


</item>






<item>
<title>Augmentation of Macular Pigment Following Implantation of Blue Light-Filtering Introcular Lenses at the Time of Cataract Surgery</title>
<link>http://arrow.dit.ie/otpomart/15</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/15</guid>
<pubDate>Wed, 21 Jul 2010 01:41:48 PDT</pubDate>
<description>
	<![CDATA[
	<p>PURPOSE. (Photo)-oxidative stress is believed to play a role in the pathogenesis of age-related macular degeneration (AMD), with the threshold for retinal damage being lowest for short-wavelength (blue) light. Macular pigment (MP), consisting of the carotenoids lutein (L), zeaxanthin (Z) and meso-Z, has a maximum absorption at 460 nm and protects the retina from (photo)-oxidative injury. This study was designed to investigate whether the blue light–filtering  properties of the Alcon AcrySof Natural intraocular lens (ANIOL)  implanted during cataract surgery affects MP optical density  (MPOD).  METHODS. Forty-two patients scheduled for cataract surgery were recruited for the study. These patients all had a preoperative best corrected visual acuity rating (BCVAR) of at least 0.5 (logMAR) in the study eye. The patients were randomized to have either the standard Alcon AcrySof three-piece acrylic intraocular lens (AIOL) (controls) or the ANIOL implanted at the time of cataract surgery. The spatial profile of MPOD (i.e., at 0.25°, 0.5°, 1.0°, and 1.75° eccentricity) was measured with customized heterochromatic flicker photometry (cHFP) 1 week before and 1 week after surgery, and at 3, 6, and 12 months after surgery. Serum concentrations of L and Z were also measured at each study visit.  RESULTS. There was a highly significant and positive correlation between all MPODs (e.g., at 0.25°) recorded 1 week before and after surgery in eyes with an AIOL implant (r = 0.915, P < 0.01; paired samples t-test, P = 0.631) and in those ANIOL implants (r = 0.868, P < 0.01; paired samples t-test, P = 0.719). Average MPOD across the retina increased significantly with time (after 3 months) in the ANIOL group (repeated-measures, general linear model, P < 0.05), but remained stable in the AIOL group (repeated-measures, general linear model, P > 0.05). There were no significant time or lens effects observed for serum L over the study period (P > 0.05). There was a significant time effect for serum Z over the study period (P < 0.05), but not a significant time/lens interaction (P > 0.05).  CONCLUSIONS. Customized HFP can reliably measure the MPOD spatial profile in the presence of lens opacity, and cataract surgery does not artifactually alter MPOD readings. This study also provides evidence that implanting an IOL that filters blue light is associated with augmentation of MPOD in the absence of raised serum concentrations of L and Z. However, further and longitudinal study is needed to assess whether the observed increase in MPOD after implantation of blue-filtering IOLs is associated with reduced risk of AMD development and/or progression.</p>

	]]>
</description>

<author>John Nolan et al.</author>


</item>






<item>
<title>Macular Pigment Optical Density in an Aging Irish Population: the Irish Longitudinal Study on Ageing</title>
<link>http://arrow.dit.ie/otpomart/14</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/14</guid>
<pubDate>Tue, 20 Jul 2010 09:04:13 PDT</pubDate>
<description>
	<![CDATA[
	<p>Purpose: The 3 carotenoids lutein, zeaxanthin, and meso-zeaxanthin, which account for the ‘yellow spot’ at the macula and which are referred to as macular pigment (MP), are believed to play a role in visual function and protect against age-related macular degeneration (AMD) via their optical and antioxidant properties. This study was undertaken to compare MP optical density (MPOD) in a population aged ≧50 years with MPOD values from a normative database of subjects aged 18–60 years. Methods: Seventy-nine subjects were recruited into this pilot study (The Irish Longitudinal Study on Ageing-TILDA). MPOD was measured using heterochromatic flicker photometry. Retinal fundus photographs, lifestyle data and general health data, were also obtained. Results: The mean ± SD age of the 79 subjects recruited into this study was 65 ± 11 years. There was a moderate, but statistically significant, age-related decline in MPOD at 0.5° in the TILDA data (r = –0.251, p = 0.045), which remained upon merging with a normative database of an additional 462 subjects aged between 18 and 67 years (r = –0.179, p = 0.000). Conclusions: We report an inverse association between MPOD and increasing age. Longitudinal data in a larger cohort of participants are required to satisfactorily investigate the relationship between the optical density of this pigment and age, and with risk for development and/or progression of AMD. This pilot study represents a first step in this endeavour.</p>

	]]>
</description>

<author>John Nolan et al.</author>


</item>






<item>
<title>Augmentation of Macular Pigment Following Supplementation with all Three Macular Carotenoids: an Exploratory Study</title>
<link>http://arrow.dit.ie/otpomart/13</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/13</guid>
<pubDate>Tue, 20 Jul 2010 07:49:02 PDT</pubDate>
<description>
	<![CDATA[
	<p>Purpose:At the macula, the carotenoids meso-zeaxanthin (MZ), lutein (L), and zeaxanthin (Z) are collectively referred to as macular pigment (MP). This study was designed to measure serum and macular responses to a macular carotenoid formulation. Materials and Methods:Ten subjects were recruited into this study (five normal and five with early age-related macular degeneration [AMD]). Subjects were instructed to consume a formulation containing 7.3mg of MZ, 3.7mg of L, and 0.8mg of Z everyday over an eight-week period. The spatial profile of MP optical density (i.e., MPOD at 0.25°, 0.5°, 1°, and 1.75°) was measured using customized heterochromatic flicker photometry, and a blood sample was collected at each study visit in order to analyze serum concentrations of MZ, L, and Z. Results:There was a significant increase in serum concentrations of MZ and L after two weeks of supplementation (p<0.05). Baseline serum carotenoid analysis detected a small peak eluting at the same time as MZ in all subjects, with a mean ± SD of 0.02±0.01 μmol/L. We report significant increases in MPOD at 0.25°, 0.5°, 1°, and average MPOD across its spatial profile after just two weeks of supplementation (p<0.05, for all). Four subjects (one normal and three AMD) who had an atypical MPOD spatial profile (i.e., central dip) at baseline had the more typical MPOD spatial profile (i.e., highest MPOD at the center) after eight weeks of supplementation. Conclusion:We report significant increases in serum concentrations of MZ and L following supplementation with MZ, L, and Z and a significant increase in MPOD, including its spatial profile, after two weeks of supplementation. Also, this study has detected the possible presence of MZ in human serum pre-supplementation and the ability of the study carotenoid formulation to rebuild central MPOD in subjects who have atypical profiles at baseline.</p>

	]]>
</description>

<author>Eithne Connolly et al.</author>


</item>






<item>
<title>Effect on Refractive Outcomes after Cataract Surgery of Intraocular Lens Constant Personalization Using the Haigis Formula</title>
<link>http://arrow.dit.ie/otpomart/12</link>
<guid isPermaLink="true">http://arrow.dit.ie/otpomart/12</guid>
<pubDate>Tue, 20 Jul 2010 07:49:01 PDT</pubDate>
<description>
	<![CDATA[
	<p>Methods Personalization of Haigis IOL constants was performed using a series of 248 suitable eyes after biometry by partial coherence interferometry (IOLMaster) and IOL prediction based on optimized IOL constants derived from pooled data from the User Group for Laser Interference Biometry web site. A mean error of prediction and a mean absolute error were then calculated using the personalized IOL constants and compared with those derived using optimized IOL constants, allowing evaluation and quantification of the maximum realizable refractive benefits (if any) of personalization. Results There was no statistically significant difference between personalized and optimized Haigis IOL constants in absolute error or the proportion of eyes within ±1.00 diopters (D), ±0.50 D, or ±0.25 D of the target postoperative refraction in all eyes, short eyes (axial length [AL] < 22 >mm; n = 19), average eyes (AL ≥22 mm and < 24.5 mm; n = 149), or long eyes (AL >24.5 mm; n = 46) (all P>.05, McNemar test). Ten eyes with a short AL had a smaller absolute error (by ≥0.30 D) in association with personalized IOL constants. Conclusion Personalized Haigis IOL constants showed marginal, but statistically nonsignificant, refractive advantages over optimized Haigis IOL constants, but only in eyes with a short AL.</p>

	]]>
</description>

<author>Sofia Charalampidou et al.</author>


</item>





</channel>
</rss>
